6 completed, 3 unknown. 3 Not applicable, 2 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 2, Unknown 1 |
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Phase 3 | 1 | Completed 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Recurrent Pterygium: new trials by email Literature Review of Recurrent Pterygium trials Research Report on Recurrent Pterygium
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Digital Colorimetric Scale for Recurrent Pterygium Scar Assessment Recurrent Pterygium, Conjunctival Scarring | Completed | Instituto de Oftalmología Fundación Conde de Valenciana | 25 | 2024-08-22 | 2026-03-09 | |
| Micro-Conjunctival Autografting Combined With Amniotic Membrane Transplantation Treating Recurrent Pterygium Trial Micro-Conjunctival Autograft Combined with Amniotic Membrane Transplantation, Conventional Autologous Conjunctival Transplantation - Recurrent Pterygium, Micro-Conjunctival Autografting Combined With Amniotic Membrane Transplantation | Not applicable | Completed | Yifeng Yu | 40 | 2021-03-01 | 2022-05-05 |
| Strategies for Management of Recurrent Pterygium Bevacizumab, 5 fluorouracil - Recurrent Pterygium | Phase 4 | Unknown | University of Nottingham | 25 | 2017-01-01 | 2017-11-14 |
| Conjunctival Autograft or Limbal Conjunctival Autograft for Recurrent Pterygium Using Mitomycin C Pterygium excision, Intraoperative mitomycin C, Conjunctival autograft - Recurrent Pterygium | Not applicable | Unknown | Sun Yat-sen University | 116 | 2016-02-01 | 2020-07-09 |
| Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection ziv-aflibercept - Neovascularization, Macular Degeneration | Phase 2 | Unknown | Rafic Hariri University Hospital | 100 | 2015-03-01 | 2018-08-29 |
| Bevacizumab Injection for Recurrent Pterygium Bevacizumab, Medical Treatment, Argon laser treatment - Recurrent Pterygium | Completed | Instituto de Oftalmología Fundación Conde de Valenciana | 38 | 2012-03-01 | 2018-03-09 | |
| Subconjunctival Bevacizumab and Recurrent Pterygium Bevacizumab - Recurrent Pterygium | Phase 2 / Phase 3 | Completed | Instituto de Olhos de Goiania | 36 | 2012-02-01 | 2012-12-07 |
| Recurrent Pterygium Surgery Using Mitomycin C With Limbal Conjunctival or Amniotic Membrane MMC, LCAG, AMG - Recurrent Pterygium | Not applicable | Completed | Shiyou Zhou | 96 | 2010-12-01 | 2015-03-19 |
| Clinical Analysis of Recurrence Patterns Following Conjunctival Autografts for Pterygium Surgery recurrent pterygium excision and following grafting - Recurrent Pterygium | Completed | Kyungpook National University Hospital | 116 | 2009-02-01 | 2014-02-11 |
Pterygium (9) · Choroidal Neovascularization (1) · Diabetic Retinopathy (1) · Macular Degeneration (1) · Macular Edema (1) · Neovascularization, Pathologic (1) · Retinal Neovascularization (1) · Retinal Vein Occlusion (1)
Conjunctival Diseases (9) · Eye Diseases (9) · Cardiovascular Diseases (1) · Choroid Diseases (1) · Diabetes Complications (1) · Diabetes Mellitus (1) · Diabetic Angiopathies (1) · Embolism and Thrombosis (1) · Endocrine System Diseases (1) · Metaplasia (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Retinal Degeneration (1) · Retinal Diseases (1) · Thrombosis (1)
Bevacizumab (3) · Fluorouracil (1) · Mitomycin (1) · aflibercept (1)
Instituto de Oftalmología Fundación Conde de Valenciana (2) · Instituto de Olhos de Goiania (1) · Kyungpook National University Hospital (1) · Rafic Hariri University Hospital (1) · Shiyou Zhou (1) · Sun Yat-sen University (1) · University of Nottingham (1) · Yifeng Yu (1)
China (3) · Mexico (2) · Brazil (1) · Lebanon (1) · South Korea (1)
Ahmad M Mansour, MD (1) · Harminder Dua, Professor (1) · Hong Kyun Kim, M.D. (1) · Jose Adrian Negrete, MD (1) · Larissa S Stival, MD (1) · Shiyou Zhou, MD, PHD (1) · Yonathan O Garfias, MD, PhD (1) · Zhou Shiyou, M.D., Ph.D. (1)
PMID 25076364, PMID 25634207, PMID 25677668, PMID 27030277, PMID 28614154, PMID 31956432